I
Initiator Pharma A/S
STO:INIT
Initiator Pharma A/S
STO:INIT
Price:
3.27
SEK
1.55%
Market Closed
Market Cap:
kr223.8m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
I
|
Initiator Pharma A/S
STO:INIT
|
DK |
|
E
|
Easy Smart Group Holdings Ltd
HKEX:2442
|
HK |
|
Seres Therapeutics Inc
NASDAQ:MCRB
|
US |
Balance Sheet
Balance Sheet Decomposition
Initiator Pharma A/S
Initiator Pharma A/S
Balance Sheet Decomposition is not available for
Initiator Pharma A/S
Initiator Pharma A/S
Balance Sheet
Initiator Pharma A/S
Initiator Pharma A/S
Currency: DKK
| Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
0
|
7
|
14
|
8
|
14
|
34
|
39
|
24
|
13
|
26
|
|
| Cash Equivalents |
0
|
7
|
14
|
8
|
14
|
34
|
39
|
24
|
13
|
26
|
|
| Total Receivables |
0
|
2
|
3
|
3
|
2
|
4
|
7
|
5
|
2
|
3
|
|
| Other Current Assets |
0
|
0
|
0
|
1
|
0
|
15
|
2
|
0
|
0
|
3
|
|
| Total Current Assets |
0
|
9
|
17
|
11
|
16
|
54
|
48
|
30
|
16
|
33
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
1
N/A
|
9
+1 561%
|
17
+86%
|
11
-34%
|
16
+36%
|
54
+244%
|
48
-10%
|
30
-38%
|
16
-47%
|
33
+108%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
0
|
0
|
0
|
1
|
1
|
5
|
1
|
0
|
0
|
1
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
0
|
1
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
1
|
3
|
1
|
0
|
1
|
1
|
1
|
0
|
0
|
1
|
|
| Total Current Liabilities |
1
|
3
|
1
|
2
|
1
|
5
|
2
|
3
|
1
|
1
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
13
|
13
|
15
|
0
|
2
|
|
| Total Liabilities |
1
N/A
|
3
+258%
|
1
-77%
|
2
+101%
|
1
-22%
|
19
+1 472%
|
14
-23%
|
19
+30%
|
1
-94%
|
3
+226%
|
|
| Equity | |||||||||||
| Retained Earnings |
1
|
5
|
14
|
7
|
12
|
30
|
29
|
6
|
9
|
22
|
|
| Additional Paid In Capital |
1
|
1
|
2
|
2
|
3
|
5
|
5
|
6
|
6
|
7
|
|
| Total Equity |
0
N/A
|
6
N/A
|
17
+178%
|
10
-40%
|
14
+45%
|
35
+143%
|
34
-3%
|
11
-67%
|
15
+32%
|
30
+100%
|
|
| Total Liabilities & Equity |
1
N/A
|
9
+1 561%
|
17
+86%
|
11
-34%
|
16
+36%
|
54
+244%
|
48
-10%
|
30
-38%
|
16
-47%
|
33
+108%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
5
|
11
|
25
|
25
|
30
|
44
|
52
|
52
|
56
|
68
|
|
Switch to:
Switch to:
See Also
Discover More
